期刊文献+
任意字段
题名或关键词
题名
关键词
摘要
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息
共找到1篇文章
< 1 >
每页显示 20 50 100
已选0条
引用分析
参考文献
引证文献
 统计分析
检索结果
已选文献
显示方式：
Technical and Implementation Guidelines for the Introduction of Human Papillomavirus Vaccine into China’s National Immunization Program 认领 引用 被引量：2
1
作者 Fuzhen Wang Lei Cao +11 位作者 Keli Li Guomin Zhang Lixin Hao Chao Ma Ning Wen Xiaoxue Liu Jiakai Ye Yan Li Yudan Song Zhijie An Wenzhou Yu Zundong Yin 《China CDC weekly》 SCIE CSCD 2025年第50期1545-1548,共4页
Human papillomavirus(HPV)vaccination administered before viral exposure(i.e.,prior to sexual debut)effectively prevents infection with vaccine-type HPV strains and associated diseases,including cervical cancer.To adva... Human papillomavirus(HPV)vaccination administered before viral exposure(i.e.,prior to sexual debut)effectively prevents infection with vaccine-type HPV strains and associated diseases,including cervical cancer.To advance HPV vaccination efforts and cervical cancer prevention,China has incorporated the bivalent HPV vaccine(types 16/18)into its National Immunization Program(NIP)as a program vaccine.This Policy Note presents comprehensive technical and implementation guidelines for HPV vaccine deployment,encompassing guidance development methodology,target population definition,routine vaccination schedules,catch-up vaccination protocols,implementation strategies,vaccine coverage and adverse event monitoring plans,and anticipated implementation challenges with proposed mitigation measures.The Vaccine Technical Working Groups of the China CDC developed relevant technical recommendations and guidelines,which were officially issued in November 2025. 展开更多
关键词 technical guidelines bivalent hpv vaccine types implementation guidelines national immunization program nip human papillomavirus vaccine national immunization program human papillomavirus hpv vaccination technical implementation guidelines
已选0条
引用分析
参考文献
引证文献
 统计分析
检索结果
已选文献
上一页 1 下一页 到第 页
在线咨询 使用帮助 返回顶部 意见反馈